Elvanse 30 mg
Elvanse 30 mg is a medicine authorised by Swissmedic under authorisation number 63023. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 27 March 2014 and the authorisation is valid without a time limit. ATC code N06BA12 places the medicine in the group Psychoanaleptics.
| Authorisation number | 63023 |
|---|---|
| Name | Elvanse 30 mg |
| Full name | Elvanse 30 mg, Hartkapseln |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N06BA12 |
| First authorisation | 27 March 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Elvanse 30 mg, Hartkapseln | A+ | 27 March 2014 |
| 2 | Elvanse 50 mg, Hartkapseln | A+ | 27 March 2014 |
| 3 | Elvanse 70 mg, Hartkapseln | A+ | 27 March 2014 |
| 4 | Elvanse 20 mg, Hartkapseln | A+ | 16 November 2016 |
| 5 | Elvanse 40 mg, Hartkapseln | A+ | 16 November 2016 |
| 6 | Elvanse 60 mg, Hartkapseln | A+ | 16 November 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 2 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 3 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 4 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 5 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
| 6 | 30 | Kapsel(n) | N06BA12 | 01.10.2. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Elvanse 30 mg authorised in Switzerland?
Yes. Elvanse 30 mg is authorised by Swissmedic under authorisation number 63023, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Elvanse 30 mg have?
Elvanse 30 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Elvanse 30 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.